Heart Failure: Pharmacologic Management by Arthur M. Feldman (English) Hardcover

The Nile on eBay   FREE SHIPPING UK WIDE   Heart Failure by Arthur M. Feldman

Now there is an up-to-date guide for optimizing pharmacologic therapy in treating patients with heart failure. Reflecting current practice at leading medical centers, Heart Failure: Pharmacologic Management provides both the biologic and pathologic underpinnings of each pharmacologic agent in current use.

FORMATHardcover LANGUAGEEnglish CONDITIONBrand New Publisher Description

Now there is an up-to-date guide for optimizing pharmacologic therapy in treating patients with heart failure. Reflecting current practice at leading medical centers, Heart Failure: Pharmacologic Management provides both the biologic and pathologic underpinnings of each pharmacologic agent in current use. It also supplies detailed discussions of the clinical investigations that support current understanding of the risks and benefits associated with the use of these drugs. Thorough references make the book useful to the novice as well as the experienced clinician.Initial chapters focus on agents that are considered standard care:diureticsACE inhibitorsangiotensin receptor antagonistsaldosterone antagonistsbeta-blockers The discussion moves to agents currently under investigation:Vasopressin antagonistserythropoietin Next, the authors consider some controversial drugs:inotropic agentsantiarrhythmic drugsanticoagulants An insightful examination of pharmacogenetics considers:how studies of the genetic profile of patients helps determine which patient populations are most likely to respond to a given class of drugsthe potential use of pharmacogenetics to tailor a pharmacologic regimen for maximum benefit and minimum risk Multidrug pharmacy for heart failure therapyAn extremely helpful concluding chapter provides a roadmap of drugs with which to approach the patient with heart failure, along with an overview of the skills you need to use it most effectively. This straightforward, step-by-step algorithm will save you countless hours of research and help you make your prescribing decisions with confidence.

Back Cover

Heart failure is a devastating disease of epidemic proportions. Physicians are faced with an increasingly large choice of treatment options and questions including: how different genetic, racial and gender backgrounds can influence a patient’s response; how to monitor treatment once it has begun; and what side-effects can be expected from these agents.Heart Failure: Pharmacologic Management is the essential guide for physicians working with these issues to optimise their use of pharmacologic therapy for patients with heart failure. This extensively referenced text provides both the biologic and pathologic underpinning for the use of eachpharmacologic agent currently recommended, including the clinical investigations that have led to our understanding of the risks and benefits associated with the use of these drugs. In addition, this book reviews several areas, including vasopressin antagonists, that are under active investigation, but which are expected to prove fruitful in the therapy of patients with heart failure.Heart Failure: Pharmacologic Management is written by individuals with extensive expertise within the field and is the only text to focus on pharmacologic therapy. It will assist the practitioner in easily making sense of the extensive number of treatment agents available and should be considered a vital contribution to your bookshelf.

Flap

Heart failure is a devastating disease of epidemic proportions. Physicians are faced with an increasingly large choice of treatment options and questions including: how different genetic, racial and gender backgrounds can influence a patient's response; how to monitor treatment once it has begun; and what side-effects can be expected from these agents. Heart Failure: Pharmacologic Management is the essential guide for physicians working with these issues to optimise their use of pharmacologic therapy for patients with heart failure. This extensively referenced text provides both the biologic and pathologic underpinning for the use of eachpharmacologic agent currently recommended, including the clinical investigations that have led to our understanding of the risks and benefits associated with the use of these drugs. In addition, this book reviews several areas, including vasopressin antagonists, that are under active investigation, but which are expected to prove fruitful in the therapy of patients with heart failure. Heart Failure: Pharmacologic Management is written by individuals with extensive expertise within the field and is the only text to focus on pharmacologic therapy. It will assist the practitioner in easily making sense of the extensive number of treatment agents available and should be considered a vital contribution to your bookshelf.

Author Biography

Arthur M. Feldman is the editor of Heart Failure: Pharmacologic Management, published by Wiley.

Table of Contents

Contributors. Introduction. 1. Diuretics in congestive heart failure (Alicia Ross, Ray E. Hershberger and David H. Ellison). 2. Use of digoxin in the treatment of heart failure (Deborah DeEugenio and Paul J. Mather). 3. Renin-angiotensin system and angiotensin converting enzyme inhibitors in chronic heart failure (Rimvida Obeleniene and Marrick Kukin). 4. Angiotensin receptor blockers in the treatment of hart failure (Anita Deswal and Douglas L. Mann). 5. Beta blockers (Peter F. Robinson and Michael R. Bristow). 6. Aldosterone antagonism in the pharmacological management of chronic heart failure (Biykem Bozkurt). 7. Inotropic therapy in clinical practice (Sharon Rubin and Theresa Pondok). 8. Antiarrhythmic therapy in heart failure (Igino Contrafatto and Leslie A. Saxon). 9. Treating the hypercoagulable state of heart failure: modifying the risk of arterial and venous thromboembolism (Geno J. Meril and Hoard H. Weitz). 10. Vasodilator and nitrates (Abdul Al-Hesayen and John D. Parker). 11. Natriuretic peptides fro the treatment of heart failure (Jonathan D. Sackner-Bernstein, Hal Skopicki and Keith D. Aaronson). 12. Immune modulatory therapies in heart failure: using myocarditis to gain mechanistic insights (Grace Chan, Koichi Fuse, Mei Sun, Bill Ayach and Peter P. Liu). 13. The role of vasopressin and vasopressin antagonists in heart failure (Olaf Hedrich, Maervin A. Konstam and James Eric Udelson). 14. Role of erythropoietin in the correction of anemia in patients with heart failure (Revecca P. Streeter and Donna M. Mancini). 15. Endothelin antagonism cardiovascular disease (Srinivas Murali). 16. Pharmacogenetics (Richard Sheppard and Dennis M. McNamara). 17. Management of diastolic dysfunction (Arthur M. Feldman and Bonita Fakner). 18. Multidrug pharmacy for treatment of heart failure: an algorithm for the clinician (Mariell Jessup). Index.

Long Description

Now there is an up-to-date guide for optimizing pharmacologic therapy in treating patients with heart failure. Reflecting current practice at leading medical centers, Heart Failure: Pharmacologic Management provides both the biologic and pathologic underpinnings of each pharmacologic agent in current use. It also supplies detailed discussions of the clinical investigations that support current understanding of the risks and benefits associated with the use of these drugs. Thorough references make the book useful to the novice as well as the experienced clinician.Initial chapters focus on agents that are considered standard care: diureticsACE inhibitorsangiotensin receptor antagonistsaldosterone antagonistsbeta-blockersThe discussion moves to agents currently under investigation: Vasopressin antagonistserythropoietinNext, the authors consider some controversial drugs: inotropic agentsantiarrhythmic drugsanticoagulantsAn insightful examination of pharmacogenetics considers: how studies of the genetic profile o patients helps determine which patient populations are most likely to respond to a given class of drugsthe potential use of pharmacogenetics to tailor a pharmacologic regimen for maximum benefit and minimum riskMultidrug pharmacy for heart failure therapyAn extremely helpful concluding chapter provides a roadmap of drugs with which to approach the patient with heart failure, along with an overview of the skills you need to use it most effectively. This straightforward, step-by-step algorithm will save you countless hours of research and help you make your prescribing decisions with confidence.

Feature

An informative guide to optimizing the use of pharmacologic therapy for patients with heart failureIncludes the biologic and pathologic underpinning for the use of each pharmacologic agent currently recommendedDiscusses agents that are considered standard care, and those still under investigation or controversialCovers the emerging field of pharmacogenetics and the genetic profile of patients

Details ISBN1405103612 Short Title HEART FAILURE Language English ISBN-10 1405103612 ISBN-13 9781405103619 Media Book Format Hardcover Illustrations Yes Year 2006 Edition 1st Edited by Arthur M. Feldman Birth 1949 Subtitle Pharmacologic Management Imprint Wiley-Blackwell DOI 10.1604/9781405103619 UK Release Date 2006-04-25 AU Release Date 2006-04-25 NZ Release Date 2006-04-25 US Release Date 2006-04-25 Author Arthur M. Feldman Pages 304 Publisher John Wiley and Sons Ltd Publication Date 2006-04-25 Place of Publication Hoboken DEWEY 616.129061 Audience Professional & Vocational Country of Publication United Kingdom We've got this

At The Nile, if you're looking for it, we've got it.With fast shipping, low prices, friendly service and well over a million items - you're bound to find what you want, at a price you'll love!

30 DAY RETURN POLICY

No questions asked, 30 day returns!

FREE DELIVERY

No matter where you are in the UK, delivery is free.

SECURE PAYMENT

Peace of mind by paying through PayPal and eBay Buyer Protection TheNile_Item_ID:13003410;